Core Viewpoint - The announcement details the progress of the exchange of convertible bonds issued by the controlling shareholder of Jiuzhoutong Pharmaceutical Group Co., Ltd., which will lead to a passive decrease in the shareholding ratio of the controlling shareholder without triggering a mandatory takeover bid [1][3]. Group 1: Exchange Bond Details - The convertible bond holders will exercise their rights from December 19, 2024, to June 9, 2025, resulting in the exchange of 14,477,602 shares, leading to a 0.29% passive decrease in the shareholding ratio of the controlling shareholder and its concerted parties [2][3]. - After the exchange, the controlling shareholder and its concerted parties will hold 45.94% of the company's shares, down from 46.23% as of December 18, 2024 [2][4]. Group 2: Shareholding Structure - The shareholding structure before and after the exchange indicates that the controlling shareholder, Chuchang Investment Group Co., Ltd., and its concerted parties will see their total shareholding decrease from 2,330,940,103 shares (46.23%) to 2,316,462,501 shares (45.94%) [4]. - The exchange will not result in a change of the controlling shareholder or actual controller of the company [3][4]. Group 3: Regulatory Compliance - The exchange of shares is in accordance with the relevant provisions of the prospectus and does not violate any laws or regulations, including the Securities Law and the Measures for the Administration of the Acquisition of Listed Companies [3]. - The company will continue to monitor the situation and fulfill its information disclosure obligations as required by law [4].